AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Imagion Biosystems

0.016

-0.001-5.88%

Volume:2.20M

Turnover:36.94K

Market Cap:3.22M

PE:-0.35

High:0.017

Open:0.017

Low:0.016

Close:0.017

Loading ...

Overview Company News Filings

Imagion Biosystems Ltd-Update to Notification Regarding Unquoted Securities

THOMSON REUTERS

Change of Director's Interest Notices - RP and BM-IBX.AX

Notification regarding unquoted securities - IBX-IBX.AX

Imagion Biosystems Says No Issues Raised After US FDA Meeting; Shares Up 29%

MT Newswires Live

Imagion Biosystems Ltd-Imagion Magsense Breast Cancer Program Phase 2 Trial Update

THOMSON REUTERS

Notification regarding unquoted securities - IBX-IBX.AX

ASX Runners of the Week: Yandal, Imagion, Falcon & Bayan

The West Australian

ASX Biggest Gainers

MT Newswires Live

Imagion Biosystems Full Year 2024 Earnings: AU$0.046 loss per share (vs AU$0.41 loss in FY 2023)

Simply Wall St.

Imagion Biosystems advances MagSense HER2 imaging agent with FDA application

Imagion Biosystems Starts Manufacturing Imaging Agent Ahead of Phase Two Clinical Study; Shares Rise 6%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IBX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBX.AU\",,,,,undefined,":{"symbol":"IBX.AU","market":"AU","secType":"STK","nameCN":"Imagion Biosystems","latestPrice":0.016,"timestamp":1752819120000,"preClose":0.017,"halted":0,"volume":2201757,"delay":0,"nameEN":"Imagion Biosystems","floatShares":140951171,"shares":201341415,"eps":-0.045989,"marketStatus":"Market Closed","change":-0.001,"latestTime":"07-18 16:12:00 AEST","open":0.017,"high":0.017,"low":0.016,"amount":36937,"amplitude":0.058824,"askPrice":0.018,"askSize":665060,"bidPrice":0.016,"bidSize":955591,"shortable":3,"etf":0,"ttmEps":-0.045989,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1753056000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.017,"openAndCloseTimeList":[[1752796800000,1752818400000]],"volumeRatio":0.1712476715269403,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBX.AU\",,,,,undefined,":{"symbol":"IBX.AU","floatShares":140951171,"roa":"-12.64%","roe":"-2804.87%","lyrEps":-0.045985,"volumeRatio":0.1712476715269403,"shares":201341415,"dividePrice":0,"high":0.017,"amplitude":0.058824,"preClose":0.017,"low":0.016,"week52Low":0.011,"pbRate":"-1.41","psRate":"1.21","week52High":0.08,"institutionHeld":0,"latestPrice":0.016,"committee":0.179268,"eps":-0.045989,"divideRate":0,"volume":2201757,"delay":0,"ttmEps":-0.045989,"open":0.017,"prevYearClose":0.023,"prevWeekClose":0.016,"prevMonthClose":0.012,"prevQuarterClose":0.012,"fiveDayClose":0.016,"twentyDayClose":0.011,"sixtyDayClose":0.014},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2552945209","title":"Imagion Biosystems Ltd-Update to Notification Regarding Unquoted Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2552945209","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552945209?lang=en_us&edition=fundamental","pubTime":"2025-07-18 14:52","pubTimestamp":1752821558,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250718:nTUE6GKHKX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","IBX.AU"],"gpt_icon":0},{"id":"2552106642","title":"Change of Director's Interest Notices - RP and BM-IBX.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2552106642","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552106642?lang=en_us&edition=fundamental","pubTime":"2025-07-17 14:44","pubTimestamp":1752734653,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250717:nASX5Yhf6Q","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nASX99JBVn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBX.AU","BK7007"],"gpt_icon":0},{"id":"2551597361","title":"Notification regarding unquoted securities - IBX-IBX.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2551597361","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551597361?lang=en_us&edition=fundamental","pubTime":"2025-07-15 14:51","pubTimestamp":1752562260,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250715:nASX6MYR28","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nASX5pmrr5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBX.AU","BK7007"],"gpt_icon":0},{"id":"2551516130","title":"Imagion Biosystems Says No Issues Raised After US FDA Meeting; Shares Up 29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551516130","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551516130?lang=en_us&edition=fundamental","pubTime":"2025-07-15 10:44","pubTimestamp":1752547449,"startTime":"0","endTime":"0","summary":"Imagion Biosystems  said no issues were identified following the meeting with the US Food and Drug Administration  on plans to undertake a phase two trial of the MagSense HER2 imaging agent in breast cancer detection, according to a Tuesday filing with the Australian bourse.The company will expedite manufacturing of the imaging agent for the trial, with final manufacturing and testing expected to be completed in the third quarter of the year, the filing said.Shares rose 29% in midday trade on Tuesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBX.AU","BK7007"],"gpt_icon":0},{"id":"2551913944","title":"Imagion Biosystems Ltd-Imagion Magsense Breast Cancer Program Phase 2 Trial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2551913944","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551913944?lang=en_us&edition=fundamental","pubTime":"2025-07-15 07:26","pubTimestamp":1752535606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nTUE6V1MHZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBX.AU","BK7007"],"gpt_icon":0},{"id":"2550479986","title":"Notification regarding unquoted securities - IBX-IBX.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2550479986","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550479986?lang=en_us&edition=fundamental","pubTime":"2025-07-11 14:44","pubTimestamp":1752216254,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250711:nASX8DwWsx","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250711:nASX3Py3Ck:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBX.AU","BK7007"],"gpt_icon":0},{"id":"2550982087","title":"ASX Runners of the Week: Yandal, Imagion, Falcon & Bayan","url":"https://stock-news.laohu8.com/highlight/detail?id=2550982087","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550982087?lang=en_us&edition=fundamental","pubTime":"2025-07-11 08:04","pubTimestamp":1752192270,"startTime":"0","endTime":"0","summary":"This week’s Bulls N’ Bears ASX Runners of the Week is… Yandal Resources, after the company identified a gold discovery of potentially massive scale in one of WA’s prolific gold belts.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-19325302/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-19325302/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-yandal-imagion-falcon-bayan-c-19325302","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-yandal-imagion-falcon-bayan-c-19325302","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["BK7095","XJO.AU","XAO.AU","IBX.AU","BK4135","AC","XKO.AU","BMM.AU","YRL.AU","BK7007","FAL.AU","BK7104"],"gpt_icon":0},{"id":"2550693732","title":"ASX Biggest Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2550693732","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550693732?lang=en_us&edition=fundamental","pubTime":"2025-07-10 10:26","pubTimestamp":1752114406,"startTime":"0","endTime":"0","summary":"Here are the 10 ASX-listed companies with the biggest gains on Thursday.Imagion Biosystems : +76%, AU$0.022Yandal Resources : +70%, AU$0.155Chariot Corporation : +40%, AU$0.077Lakes Blue Energy : +32%, AU$1.19DY6 Metals : +28%, AU$0.295Summit Minerals : +22%, AU$0.055Change Financial : +21%, AU$0.085Prospech : +19%, AU$0.019Australian Critical Minerals : +18%, AU$0.065Codeifai : +17%, AU$0.028","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","PRS.AU","CDE.AU","CC9.AU","LKO.AU","YRL.AU","BK7050","BK7033","ACM.AU","CCA.AU","BK7104","BK7142","DY6.AU","SUM.AU","BK7158","BK7095","IBX.AU"],"gpt_icon":0},{"id":"2516567796","title":"Imagion Biosystems Full Year 2024 Earnings: AU$0.046 loss per share (vs AU$0.41 loss in FY 2023)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516567796","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516567796?lang=en_us&edition=fundamental","pubTime":"2025-03-02 07:49","pubTimestamp":1740872981,"startTime":"0","endTime":"0","summary":"ASX:IBX Earnings and Revenue History March 1st 2025. All figures shown in the chart above are for the trailing 12 month  period. Imagion Biosystems' share price is broadly unchanged from a week ago.You should always think about risks. Case in point, we've spotted   6 warning signs for Imagion Biosystems  you should be aware of, and 5 of them are significant.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/imagion-biosystems-full-2024-earnings-234941529.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["IBX.AU"],"gpt_icon":0},{"id":"2512142285","title":"Imagion Biosystems advances MagSense HER2 imaging agent with FDA application","url":"https://stock-news.laohu8.com/highlight/detail?id=2512142285","media":"Small Caps","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512142285?lang=en_us&edition=fundamental","pubTime":"2025-02-19 10:21","pubTimestamp":1739931666,"startTime":"0","endTime":"0","summary":"Cancer detection specialist Imagion Biosystems  has taken the next step in progressing its MagSense HER2 imaging agent, lodging an application with the US Food and Drug Administration .The application for initiated manufacturing of MagSense HER2 is an essential requirement for filing an Investigational New Drug  application with the FDA in mid-2025.The company is developing MagSense HER2 to assist with the assessment of axillary nodal disease in patients diagnosed with HER2+ breast cancer.The HER2-positive subtype of breast cancer is an aggressive phenotype with a high rate of recurrence and metastasis, leading to the need for the development of a more sensitive and specific imaging method.Ultrasound is currently the most commonly employed method for assessing HER2+, with pooled diagnostic sensitivity and specificity of 49% to 87% and 55% to 97%, respectively.Imagion executive chair Bob Proulx said precise nodal staging is an essential component in the management of patients with breas","market":"us","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/02/Imagion-Biosystems-ASX-IBX-Initiates-Manufacturing-MagSense-breast-cancer.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/02/Imagion-Biosystems-ASX-IBX-Initiates-Manufacturing-MagSense-breast-cancer.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/imagion-biosystems-magsense-her2-imaging-agent-fda-application/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["BK7095","IND.AU","BK7007","IBX.AU"],"gpt_icon":0},{"id":"2512814873","title":"Imagion Biosystems Starts Manufacturing Imaging Agent Ahead of Phase Two Clinical Study; Shares Rise 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512814873","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512814873?lang=en_us&edition=fundamental","pubTime":"2025-02-19 09:48","pubTimestamp":1739929684,"startTime":"0","endTime":"0","summary":"Imagion Biosystems (ASX:IBX) started manufacturing the MagSense HER2 imaging agent for its phase two clinical study, a requirement for filing an investigational new drug application with the US Food a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","IBX.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2023-11-16","symbol":"IBX.AU","defaultRemindTime":1700089200000,"type":"split","dateTimestamp":1700053200000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBX.AU\",market:\"AU\",,,undefined,":[]}}